SLC15A4 inhibitor therapy (OMass Therapeutics)

N/A

Report date: 2024/09/18 15:50:59
NME

Base Information

Drug NameSLC15A4 inhibitor therapy (OMass Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 15 member 4 inhibitors
TargetsSolute carrier family 15 member 4
Therapy Area/IndicationsLupus Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOMass Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOMass Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLupus Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A